نتایج جستجو برای: chelation

تعداد نتایج: 4658  

M Hadipour Dehshal, M Karimi, MR Shah Ahmad Ghasemi,

Background: Thalassemia is a series of hemoglobinopathies in which the production of perfect hemoglobin is completely or partially suppressed. Using injectable iron chelators have been dominating treatment for the iron overload caused by recurrent blood transfusions in thalassemic patients, however, a new oral iron chelating drug (Exjade) have been recently introduced and might be cost effec...

Journal: :Proceedings of the Royal Society of Medicine 1964

Journal: :Biomedical Journal of Scientific & Technical Research 2020

Journal: :JAMA 2013
Gervasio A Lamas Christine Goertz Robin Boineau Daniel B Mark Theodore Rozema Richard L Nahin Lauren Lindblad Eldrin F Lewis Jeanne Drisko Kerry L Lee

IMPORTANCE Chelation therapy with disodium EDTA has been used for more than 50 years to treat atherosclerosis without proof of efficacy. OBJECTIVE To determine if an EDTA-based chelation regimen reduces cardiovascular events. DESIGN, SETTING, AND PARTICIPANTS Double-blind, placebo-controlled, 2 × 2 factorial randomized trial enrolling 1708 patients aged 50 years or older who had experienced...

Journal: :International Journal of Environmental Research and Public Health 2010

Journal: :Medical Council 2016

Journal: :Circulation 1994
A M van Rij C Solomon S G Packer W G Hopkins

BACKGROUND The use of repeated intravenous infusions of EDTA, which has become known as "chelation therapy," has been promoted for treating intermittent claudication as well as a wide range of other disorders. Multiple reports of excellent results in large numbers of patients have encouraged the use of this regimen. The lack of well-controlled studies substantiating the benefits of this treatme...

2015
Harpreet Kochhar Chantal S. Leger Heather A. Leitch

Background. Hematologic improvement (HI) occurs in some patients with acquired anemias and transfusional iron overload receiving iron chelation therapy (ICT) but there is little information on transfusion status after stopping chelation. Case Report. A patient with low IPSS risk RARS-T evolved to myelofibrosis developed a regular red blood cell (RBC) transfusion requirement. There was no respon...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید